Refine
Has Fulltext
- yes (31)
Is part of the Bibliography
- yes (31)
Year of publication
Document Type
- Journal article (30)
- Doctoral Thesis (1)
Language
- English (31) (remove)
Keywords
- brain (31) (remove)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (7)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (4)
- Neurochirurgische Klinik und Poliklinik (4)
- Pathologisches Institut (4)
- Institut für Psychologie (3)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (3)
- Neurologische Klinik und Poliklinik (3)
- Graduate School of Life Sciences (2)
- Institut für Anatomie und Zellbiologie (2)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (2)
Objective: We investigated cerebral opioid receptor binding potential in patients with fibromyalgia syndrome (FMS) using positron-emission-tomography (PET) and correlated our results with patients’ systemic interleukin-4 (IL-4) gene expression.
Methods: In this pilot study, seven FMS patients (1 man, 6 women) agreed to participate in experimental PET scans. All patients underwent neurological examination, were investigated with questionnaires for pain, depression, and FMS symptoms. Additionally, blood for IL-4 gene expression analysis was withdrawn at two time points with a median latency of 1.3 years. Patients were investigated in a PET scanner using the opioid receptor ligand F-18-fluoro-ethyl-diprenorphine ([18F]FEDPN) and results were compared with laboratory normative values.
Results: Neurological examination was normal in all FMS patients. Reduced opioid receptor binding was found in mid cingulate cortex compared to healthy controls (p < 0.005). Interestingly, three patients with high systemic IL-4 gene expression had increased opioid receptor binding in the fronto-basal cortex compared to those with low IL-4 gene expression (p < 0.005).
Conclusion: Our data give further evidence for a reduction in cortical opioid receptor availability in FMS patients as another potential central nervous system contributor to pain in FMS.